7B2 chaperone knockout in APP model mice results in reduced plaque burden

Area of Science:

• Neuroscience
• Molecular Biology
• Alzheimer's Disease Research

Background:

• Neuronal proteostasis impairment is central to Alzheimer's disease (AD).
• Mechanisms of protein aggregation and the role of secretory chaperones are unclear.
• The neural-specific chaperone 7B2 inhibits amyloid-beta 42 (Aβ42) fibrillation in vitro.

Purpose of the Study:

• To investigate the in vivo function of chaperone 7B2 in Alzheimer's disease.
• To assess the impact of 7B2 deficiency on amyloid plaque formation and behavior in a mouse model.

Main Methods:

• Generation of 7B2-deficient mice on an hAPPswe/PS1dE9 Alzheimer's model background.
• Immunocytochemical analysis of amyloid plaque burden (Thioflavin S and Aβ staining).
• Measurement of soluble and insoluble Aβ levels.
• Behavioral testing using the Morris water maze.

Main Results:

• Reduced number and burden of Thioflavin S-reactive and Aβ-immunoreactive plaques in 7B2-deficient mice.
• No significant change in total soluble or insoluble Aβ levels.
• 7B2 deficiency did not affect cognitive performance in the Morris water maze.

Conclusions:

• Brain 7B2 facilitates amyloid plaque formation in the hAPPswe/PS1dE9 Alzheimer's model.
• Loss of 7B2 reduces amyloid plaque burden, suggesting a role in Aβ disposition.
• Findings align with previous studies on clusterin deficiency in similar models.